coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Anfield & Everton PCN, Liverpool (LAD) · Health Inequalities Profile

    PCN U49727 · NHS Cheshire and Merseyside Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    33,759

    Registered population

    63.7% aged 18–64

    15.4%

    Aged 65+

    ICB 19.0% · England 17.9%

    19.2%

    Ethnic minority (non-White)

    7.0% Asian · England 9.6%

    95.6%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~27,827

    Core20 residents (est.)

    Resident basis; registered basis ~32,121 · see page 3

    4,779

    Hypertension register

    +0.64% in 3 yrs · England +5.60%

    600

    SMI register

    7.1% of Liverpool (LAD)'s

    1,470

    COPD register

    Reviews +13.06% in 3 yrs

    Forecast to 2030

    5,031

    Hypertension patients, 2030

    +252 on today

    64.9%

    QRISK ≥20% on statins, 2030

    +0.04pp over 3 yrs

    3.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    48.4%
    Non-frail diabetes glycaemic control trails benchmarks.

    Only 48.4% (850 of 1,756 patients) achieve HbA1c at or below 58 mmol/mol versus 53.6% in Liverpool, 56.2% in the ICB and 57.4% nationally.

    61.6%
    Pre-school booster uptake lags the target.

    Age-5 4-in-1 booster coverage is 61.6% in Q1 2025/26, below the 95.0% target by 33.4 pp (ICB 82.9%, England 80.9%).

    75.4%
    Diabetes primary-prevention statin prescribing exceeds England.

    Statin treatment in diabetes without CVD reaches 75.4% (Liverpool 71.6%, ICB 72.4%, England 73.2%), rising +5.3% over 2023 to 2025 (England +2.1%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger demographic with 20.9% aged 0-17 and 15.4% aged 65+ may shape demand

    Across 33,759 registered patients, 20.9% (7,060 patients) are aged 0-17 (Liverpool 19.8%, ICB 19.2%, England 19.6%) and 15.4% (5,192 patients) are aged 65+ (Liverpool 15.6%, ICB 19.0%, England 17.9%). By Census usual residents, 80.8% are White (Liverpool 84.0%, ICB 93.0%, England 81.1%), giving a 19.2% ethnic minority share, with Asian (7.0%) and Black (5.0%) residents exceeding ICB levels. At Islington House Medical Centre, White residents comprise 74.8% and Asian residents 11.7%. Projected population growth to 2030 is 2.5% (Liverpool 3.0%, ICB 2.3%, England 2.3%), though projection methodology is unverified.

    Age profile

    0–1720.9%
    18–6463.7%
    65+15.4%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White80.8%
    Asian7.0%
    Black5.0%
    Other4.2%
    Mixed3.0%

    Older people · falls rows are Liverpool (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Liverpool LA)3,0352,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)80.1%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)48.4%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Liverpool LA)1,6521,0219552024/25
    Falls deaths, all ages, per 100,000 (Liverpool LA)27.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation is pervasive across the network with 95.6% of patients in Core20 areas

    Across the PCN, 95.6% of registered patients live in Core20 areas, above Liverpool (54.9%), the ICB (31.9%) and England (21.0%), with an average IMD decile of 1.5 (England 5.5). Priory Medical Centre has the largest volume at an estimated 9,887 Core20 patients. Concentration reaches 100.0% at Mere Lane Group Practice, while Islington House Medical Centre records 83.9%. Great Homer Street Medical Centre also records 100.0%, spanning a practice range of 16.1 pp. Resident Core20 estimates (27,827) and registered lists use different bases.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Mere Lane100.0% · 8,425 patients
    Great Homer100.0% · 3,419 patients
    Townsend96.5% · 5,376 patients
    Priory95.3% · 9,887 patients
    Islington House83.9% · 5,014 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    600

    SMI register

    1.73% recorded prevalence

    188

    Learning disability register

    0.54% recorded prevalence

    11

    Care homes, 471 beds

    In the PCN catchment

    10.3%

    Provide unpaid care

    Liverpool (LAD), Census 2021

    Recorded severe mental illness prevalence is 1.7% (600 patients), above Liverpool (1.4%), the ICB (1.1%) and England (1.0%), while learning disability prevalence is 0.5% (188 patients; comparators 0.6%). Catchment facilities include 11 care homes with 471 beds, though capacity does not establish registered residents. Severe mental illness prevalence is above Liverpool, the ICB and England, so physical-health checks for this cohort may be the larger workload to protect.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 1.7% (England 1.0%). Annual SMI blood pressure checks (76.6%) and BMI checks (74.9%) trail England (83.4% and 82.1%). Physical health monitoring requires prioritisation across the severe mental illness cohort.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,779

    Hypertension register

    +0.64%

    Register growth, 3 yrs

    Liverpool (LAD) +2.01% · England +5.60%

    +5.92pp

    BP control, under 80

    ≤140/90 · −1.31pp aged 80+

    +252

    More patients by 2030

    Forecast 5,031 (13.94%)

    Hypertension case-finding and control

    Hypertension prevalence is 13.8% (4,779 patients), below England (15.2%), Liverpool (14.0%) and the ICB (16.8%), while three-year register growth of +0.6% trails England (+5.6%). Blood pressure control under 80 is 63.6%, lagging England (67.8%), Liverpool (67.0%) and the ICB (66.4%), despite recent readings reaching 87.6%. For patients aged 80 and over, control is 79.5% (England 81.2%), falling 1.6% over three years (England +2.2%). Register differences are unadjusted for age and do not confirm under-detection. Lower blood pressure control under age 80 than England indicates an opportunity to prioritise systematic medication titration and recall across the PCN.

    Lipids and statins

    Statin uptake reaches 64.8% for QRISK ≥ 20% patients (England 63.6%) and 75.4% in diabetes without CVD (England 73.2%), though QRISK therapy growth stalled at +0.1% over three years (England +6.2%). Stalled growth despite higher uptake than England indicates a need to prioritise reviewing eligible high-risk patients not currently prescribed therapy.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202665,370£1.50£1.71£1.86£98,055
    Cardiovascular (all), 202592,737£4.33£4.37£3.33£401,551

    In 2026, 65,370 items were prescribed for lipid-regulating drugs at £1.50 per item, below England (£1.86), Liverpool (£1.82) and the ICB (£1.71). Across these items, the PCN spent £23,533 less than at England's unit cost. Lower unit spend than England allows the PCN to prioritise therapy optimisation and review rather than cost reduction.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +11.85%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.44%

    Asthma prevalence, PCN 3-yr % change

    Recorded COPD prevalence is 4.2% (1,470 patients), exceeding Liverpool (3.0%), the ICB (2.5%) and England (1.9%), though prevalence fell 6.3% over three years (England +2.6%). While COPD reviews reached 77.2% (England 76.4%), asthma reviews trail at 62.2% (England 65.7%, Liverpool 64.3%), leaving about 860 patients unreviewed. Paediatric asthma prescribing reaches 3,934 items per 1,000 aged 5-19 (England 1,488 rate). Proactive asthma recall and inhaler management require prioritisation alongside sustained COPD reviews to manage high community respiratory need.

    Cancer register and children's immunisation

    Recorded cancer prevalence is 3.1% (1,077 patients; England 3.8%, ICB 4.3%). In childhood immunisation (Q1 2025/26), age-5 MMR dose 2 coverage is 66.3% (ICB 84.4%, England 82.8%) against the 95.0% target. The 4-in-1 booster coverage is 61.6% (ICB 82.9%, England 80.9%). Pre-school booster shortfalls leave children unprotected before school entry, requiring systematic call-and-recall.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months84.4%

    England 91.0%

    6-in-1 complete primary course at 24 months82.8%

    England 92.2%

    MMR dose 1 at 24 months82.8%

    England 88.3%

    MMR dose 2 at age 566.3%

    England 82.8%

    4-in-1 pre-school booster at age 561.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Across NHS Cheshire and Merseyside ICB in 2022, 55.5% of staged cancers (7,482 of 13,490 with a known stage; 72.8% staged overall) were diagnosed at stage 1 or 2, against 55.3% in England, sitting 19.5 pp below the 75.0% national ambition and requiring about 2,640 extra early-stage diagnoses. ICB early-stage share rose 2.6 pp from 2013 to 2022. This system data does not represent PCN performance. Locally, cervical screening in women aged 25-49 is 56.1% (England 66.8%), falling 2.4% over three years (England -1.0%), while breast screening is 64.0% (England 69.9%). Screening uptake below national benchmarks could delay early cancer identification.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional Jul 2026 data, Liverpool Women's NHS Foundation Trust achieved 75.7% on the 28-day faster diagnosis standard (standard 75.0%), above Liverpool University Hospitals NHS Foundation Trust (75.5%) but below the ICB (77.2%) and England (79.3%). On the 62-day standard, Liverpool Women's reached 69.1% (standard 85.0%), lagging Liverpool University Hospitals (73.3%), the ICB (76.2%) and England (71.2%). Across all diagnostic tests, 6.5% waited 6+ weeks at Liverpool Women's, compared to 11.5% at Liverpool University Hospitals and 23.1% in England. Acute waiting times reflect system provider pressures rather than primary care delivery.

    Pathways within standard (%)Liverpool Women'sLiverpoolMersey and West LancashireCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)75.7375.4772.3977.2579.32
    31-day treatment (96%)85.4290.5195.4695.7192.50
    62-day referral to treatment (85%)69.0973.2677.9676.2371.16
    Community services activityLiverpool residentsCheshire and Merseyside ICB
    Care contacts127,380541,280
    Referrals15,67597,150
    Patients with a contact24,970146,240

    Community services (residents of Liverpool), Jun 2026 (provisional). Provisional data for Jun 2026 recorded 162,760 community care activities for Liverpool residents and 1,332,205 across NHS Cheshire and Merseyside Integrated Care Board. Older adults aged 65+ accounted for 65.4% of Liverpool contacts (83,300 of 127,380), though these figures reflect wider resident activity rather than PCN delivery. Coordinating with community services may help support the network's older residents.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Ease of phone contact varies across practices by 42.7 pp, from 29.9% to 72.6%

    In 2025/26, England overall QOF achievement was 92.5%. Mere Lane Group Practice achieved 80.8%, while Islington House Medical Centre achieved 90.4%.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Islington House10183.970.3%85.8%87.3%
    Priory12195.332.9%72.1%74.4%
    Great Homer85100.064.8%59.3%73.6%
    Townsend11596.572.6%68.8%71.0%
    Mere Lane74100.029.9%69.7%59.6%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNLiverpool (LAD)AssetPCNLiverpool (LAD)
    Care homes (catchment)11 (471 beds)n/aSchools (catchment)77n/a
    Children's centres326Places of worship31240
    Libraries117Homelessness support (VCS)n/a1
    Primary schools (LA maintained)991Primary academies320
    Special schoolsn/a8

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and inhaler recall

    Asthma annual reviews: 62.2% reviewed in 12 months (Liverpool 64.3%, England 65.7%; denominator includes PCAs), leaving an estimated 859 (about 860) of 2,271 register patients unreviewed. For discussion: practices could run a single-template asthma recall combining annual reviews with inhaler prescribing checks and flexible after-school or holiday slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Combined physical health checks for SMI

    SMI register (600 patients; 1.7% vs England 1.0%): 12-month BP checks at 76.6% (Liverpool 79.8%, ICB 81.3%, England 83.4%) and BMI checks at 74.9% (England 82.1%); patient count not sized. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Hypertension titration and BP control recall

    Hypertension register (4,779 patients; 13.8% vs England 15.2%): BP <= 140/90 mmHg under age 80 is 63.6% (ICB 66.4%, Liverpool 67.0%, England 67.8%, incl. PCAs); patient gap not sized. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Language and communication access review (p2)WhiteNeighbourhood health framework · Core20PLUS5 approachPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure control audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and access review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Structured asthma review and inhaler recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Combined physical health checks for SMI (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Option 3 · Hypertension titration and BP control recall (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15